rs76759170

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020975.6(RET):​c.*1591G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0423 in 396,966 control chromosomes in the GnomAD database, including 459 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.039 ( 142 hom., cov: 33)
Exomes 𝑓: 0.044 ( 317 hom. )

Consequence

RET
NM_020975.6 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.487

Publications

8 publications found
Variant links:
Genes affected
RET (HGNC:9967): (ret proto-oncogene) This gene encodes a transmembrane receptor and member of the tyrosine protein kinase family of proteins. Binding of ligands such as GDNF (glial cell-line derived neurotrophic factor) and other related proteins to the encoded receptor stimulates receptor dimerization and activation of downstream signaling pathways that play a role in cell differentiation, growth, migration and survival. The encoded receptor is important in development of the nervous system, and the development of organs and tissues derived from the neural crest. This proto-oncogene can undergo oncogenic activation through both cytogenetic rearrangement and activating point mutations. Mutations in this gene are associated with Hirschsprung disease and central hypoventilation syndrome and have been identified in patients with renal agenesis. [provided by RefSeq, Sep 2017]
RET Gene-Disease associations (from GenCC):
  • familial medullary thyroid carcinoma
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • multiple endocrine neoplasia type 2A
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P
  • multiple endocrine neoplasia type 2B
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
  • pheochromocytoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Hirschsprung disease, susceptibility to, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Haddad syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Hirschsprung disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis, unilateral
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • bilateral renal agenesis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • renal agenesis
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 10-43129860-G-A is Benign according to our data. Variant chr10-43129860-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 299937.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0801 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_020975.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
NM_020975.6
MANE Select
c.*1591G>A
3_prime_UTR
Exon 20 of 20NP_066124.1
RET
NM_001406743.1
c.*359G>A
3_prime_UTR
Exon 21 of 21NP_001393672.1
RET
NM_001406744.1
c.*209G>A
3_prime_UTR
Exon 20 of 20NP_001393673.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RET
ENST00000355710.8
TSL:5 MANE Select
c.*1591G>A
3_prime_UTR
Exon 20 of 20ENSP00000347942.3
RET
ENST00000615310.5
TSL:5
c.*3106G>A
3_prime_UTR
Exon 17 of 17ENSP00000480088.2
RET
ENST00000935253.1
c.*1591G>A
3_prime_UTR
Exon 16 of 16ENSP00000605312.1

Frequencies

GnomAD3 genomes
AF:
0.0389
AC:
5916
AN:
152144
Hom.:
142
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0230
Gnomad AMI
AF:
0.0998
Gnomad AMR
AF:
0.0365
Gnomad ASJ
AF:
0.0531
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.0867
Gnomad FIN
AF:
0.0315
Gnomad MID
AF:
0.0633
Gnomad NFE
AF:
0.0476
Gnomad OTH
AF:
0.0540
GnomAD4 exome
AF:
0.0444
AC:
10873
AN:
244702
Hom.:
317
Cov.:
0
AF XY:
0.0453
AC XY:
5612
AN XY:
124016
show subpopulations
African (AFR)
AF:
0.0208
AC:
149
AN:
7154
American (AMR)
AF:
0.0322
AC:
238
AN:
7380
Ashkenazi Jewish (ASJ)
AF:
0.0568
AC:
522
AN:
9198
East Asian (EAS)
AF:
0.00101
AC:
23
AN:
22750
South Asian (SAS)
AF:
0.0904
AC:
246
AN:
2720
European-Finnish (FIN)
AF:
0.0388
AC:
813
AN:
20946
Middle Eastern (MID)
AF:
0.0836
AC:
108
AN:
1292
European-Non Finnish (NFE)
AF:
0.0510
AC:
8003
AN:
157014
Other (OTH)
AF:
0.0475
AC:
771
AN:
16248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
558
1115
1673
2230
2788
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0389
AC:
5925
AN:
152264
Hom.:
142
Cov.:
33
AF XY:
0.0392
AC XY:
2918
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.0232
AC:
963
AN:
41560
American (AMR)
AF:
0.0365
AC:
558
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0531
AC:
184
AN:
3468
East Asian (EAS)
AF:
0.000964
AC:
5
AN:
5188
South Asian (SAS)
AF:
0.0870
AC:
420
AN:
4828
European-Finnish (FIN)
AF:
0.0315
AC:
333
AN:
10584
Middle Eastern (MID)
AF:
0.0646
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
0.0476
AC:
3240
AN:
68016
Other (OTH)
AF:
0.0530
AC:
112
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
296
592
888
1184
1480
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0404
Hom.:
45
Bravo
AF:
0.0377
Asia WGS
AF:
0.0320
AC:
110
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Hirschsprung disease, susceptibility to, 1 (1)
-
-
1
Multiple endocrine neoplasia (1)
-
-
1
Pheochromocytoma (1)
-
-
1
Renal hypodysplasia/aplasia 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
8.8
DANN
Benign
0.75
PhyloP100
0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76759170; hg19: chr10-43625308; API